414
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis

, ORCID Icon, ORCID Icon, ORCID Icon, , , & ORCID Icon show all
Pages 3937-3951 | Published online: 03 Jun 2020

References

  • Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel J-F. Ulcerative colitis. Lancet. 2017;389:1756–1770. doi:10.1016/S0140-6736(16)32126-227914657
  • Antoni L, Nuding S, Wehkamp J, Stange EF. Intestinal barrier in inflammatory bowel disease. World J Gastroenterol. 2014;20(5):1165–1179. doi:10.3748/wjg.v20.i5.116524574793
  • Sharara AI, Awadhi SA, Alharbi O, et al. Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East. Expert Rev Gastroenterol Hepatol. 2018;12(9):883–897. doi:10.1080/17474124.2018.150305230096985
  • Jacques C, Corinne G-R, Philippe S, Antoine C. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140(6):1785–1794. doi:10.1053/j.gastro.2011.01.05521530745
  • Panes J, Alfaro I. New treatment strategies for ulcerative colitis. Expert Rev Clin Immunol. 2017;13(10):963–973. doi:10.1080/1744666X.2017.134366828617055
  • Suntar I, Cevik CK, Ceribasi AO, Gokbulut A. Healing effects of Cornus mas L. in experimentally induced ulcerative colitis in rats: from ethnobotany to pharmacology. J Ethnopharmacol. 2020;248:112322. doi:10.1016/j.jep.2019.11232231644942
  • Batista JA, Magalhaes DDA, Sousa SG, et al. Polysaccharides derived from Morinda citrifolia Linn reduce inflammatory markers during experimental colitis. J Ethnopharmacol. 2020;248:112303. doi:10.1016/j.jep.2019.11230331614204
  • Akkol EK, Dereli FTG, Tastan H, Sobarzo-Sanchez E, Khan H. Effect of Sorbus domestica and its active constituents in an experimental model of colitis rats induced by acetic acid. J Ethnopharmacol. 2019;251:112521. doi:10.1016/j.jep.2019.11252131883473
  • Alabi QK, Akomolafe RO, Omole JG, et al. Polyphenol-rich extract of Ocimum gratissimum leaves ameliorates colitis via attenuating colonic mucosa injury and regulating pro-inflammatory cytokines production and oxidative stress. Biomed Pharmacother. 2018;103:812–822. doi:10.1016/j.biopha.2018.04.07129684860
  • Lin CH, Chen CH, Lin ZC, Fang JY. Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers. J Food Drug Anal. 2017;25(2):219–234. doi:10.1016/j.jfda.2017.02.00128911663
  • Ma C, Battat R, Dulai PS, et al. Innovations in oral therapies for inflammatory bowel disease. Drugs. 2019;79(12):1321–1335. doi:10.1007/s40265-019-01169-y31317509
  • Gao C, Liu L, Zhou Y, Bian Z, Wang S, Wang Y. Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease. Chin Med. 2019;14:23. doi:10.1186/s13020-019-0245-x31236131
  • Habtemariam S. Berberine and inflammatory bowel disease: a concise review. Pharmacol Res. 2016;113:592–599. doi:10.1016/j.phrs.2016.09.04127697643
  • Liu S, Lee H, Hung C, Tsai C, Li T, Tang C. Berberine attenuates CCN2-induced IL-1β expression and prevents cartilage degradation in a rat model of osteoarthritis. Toxicol Appl Pharmacol. 2015;289:20–29. doi:10.1016/j.taap.2015.08.02026344001
  • Cheng F, Wang Y, Li J, et al. Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans. Int J Cardiol. 2013;167(3):936–942. doi:10.1016/j.ijcard.2012.03.09022465347
  • Chang W, Chen L, Hatch GM. Berberine as a therapy for type 2 diabetes and its complications: from mechanism of action to clinical studies. Biochem Cell Biol. 2015;93(5):479–486. doi:10.1097/MD.000000000001694725607236
  • Mirhadia E, Rezaeeb M, Nikouei BM. Nano strategies for berberine delivery, a natural alkaloid of Berberis. Biomed Pharmacother. 2018;104:465–473. doi:10.1016/j.biopha.2018.05.06729793179
  • Yu F, Li M, Yuan Z, et al. Mechanism research on a bioactive resveratrol- PLA-gelatin porous nano-scaffold in promoting the repair of cartilage defect. Int J Nanomedicine. 2018;13:7845–7858. doi:10.2147/IJN.S18185530538463
  • Ibrahim S, Tagami T, Kishi T, Ozeki T. Curcumin marinosomes as promising nano-drug delivery system for lung cancer. Int J Pharm. 2018;540:40–49. doi:10.1016/j.ijpharm.2018.01.05129408473
  • Wang L, Feng M, Li Y, et al. Fabrication of superparamagnetic nano-silica@ quercetin-encapsulated PLGA nanocomposite: potential application for cardiovascular diseases. J Photochem Photobiol B. 2019;196:111508. doi:10.1016/j.jphotobiol.2019.05.00531152936
  • Saedi A, Rostamizadeh K, Parsa M, Dalali N, Ahmadi N. Preparation and characterization of nanostructured lipid carriers as drug delivery system: influence of liquid lipid types on loading and cytotoxicity. Chem Phys Lipids. 2018;216:65–72. doi:10.1016/j.chemphyslip.2018.09.00730219661
  • Behbahani ES, Ghaedi M, Abbaspour M, Rostamizadeh K. Optimization and characterization of ultrasound assisted preparation of curcumin-loaded solid lipid nanoparticles: application of central composite design, thermal analysis and X-ray diffraction techniques. Ultrason Sonochem. 2017;38:271–280. doi:10.1016/j.ultsonch.2017.03.01328633826
  • Yang B, Jiang J, Jiang L, et al. Chitosan mediated solid lipid nanoparticles for enhanced liver delivery of zedoary turmeric oil in vivo. Int J Biol Macromol. 2020;149:108–115. doi:10.1016/j.ijbiomac.2020.01.22231987952
  • Yu Q, Hu X, Ma Y, et al. Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus. Drug Deliv. 2016;23(4):1469–1475. doi:10.3109/10717544.2016.115374427187522
  • Montoto SS, Sbaraglini ML, Talevi A, et al. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: physicochemical characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces. 2018;167:73–81. doi:10.1016/j.colsurfb.2018.03.05229627680
  • Fathi HA, Allam A, Elsabahy M, Fetih G, El-Badry M. Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin. Colloids Surf B Biointerfaces. 2018;162:236–245. doi:10.1016/j.colsurfb.2017.11.06429197789
  • Zhang Y, Cui Y, Gao L, Jiang H. Effects of β-cyclodextrin on the intestinal absorption of berberine hydrochloride, a P-glycoprotein substrate. Int J Biol Macromol. 2013;59:363–371. doi:10.1016/j.ijbiomac.2013.04.07423664937
  • Jadert C, Phillipson M, Holm L, Lundberg JO, Borniquel S. Preventive and therapeutic effects of nitrite supplementation in experimental inflammatory bowel disease. Redox Biol. 2014;2:73–81. doi:10.1016/j.redox.2013.12.01224494186
  • Lian L, Zhang S, Yu Z, et al. The dietary freeze-dried fruit powder of Actinidia arguta ameliorates dextran sulphate sodium-induced ulcerative colitis in mice by inhibiting the activation of MAPKs. Food Funct. 2019;10(9):5768–5778. doi:10.1039/C9FO00664H31454000
  • Zhang Z, Li S, Cao H, et al. The protective role of phloretin against dextran sulfate sodium-induced ulcerative colitis in mice. Food Funct. 2019;10(1):422–431. doi:10.1039/c8fo01699b30604787
  • Valero MS, González M, Ramón-Gimenez M, et al. Jasonia glutinosa (L.) DC., a traditional herbal medicine, reduces inflammation, oxidative stress and protects the intestinal barrier in a murine model of colitis. Inflammopharmacology. 2019;2019:1–18. doi:10.1007/s10787-019-00626-0
  • Han S, Gao H, Chen S, et al. Procyanidin A1 alleviates inflammatory response induced by LPS through NF-κB, MAPK, and Nrf2/HO-1 pathways in RAW264.7 cells. Sci Rep. 2019;9:15087. doi:10.1038/s41598-019-51614-x31636354
  • Chen H, Chang X, Du D, et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release. 2006;110(2):296–306. doi:10.1016/j.jconrel.2005.09.05216325954
  • Rui H, Hua Z, Cao J, Davoudi Z, Wang Q. Synthesis and in vitro characterization of carboxymethyl chitosan-CBA-doxorubicin conjugate nanoparticles as pH-sensitive drug delivery systems. J Biomed Nanotechnol. 2017;13(9):1097–1105. doi:10.1166/jbn.2017.240731251142
  • Hu R, Zheng H, Cao J, Davoudi Z, Wang Q. Self-assembled hyaluronic acid nanoparticles for pH-sensitive release of doxorubicin: synthesis and in vitro characterization. J Biomed Nanotechnol. 2017;13(9):1058–1068. doi:10.1166/jbn.2017.240631251139
  • Zheng Y, Lv X, Xu Y, Cheng X, Wang X, Tang R. pH-sensitive and pluronic-modified pullulan nanogels for greatly improved antitumor in vivo. Int J Biol Macromol. 2019;139:277–289. doi:10.1016/j.ijbiomac.2019.07.22031377289
  • Martina P, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol. 2012;2012:718617. doi:10.1155/2012/71861722665990
  • Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):1–10. doi:10.1101/cshperspect.a001651
  • Liu Y, Kim S, Kim YJ, et al. Green synthesis of gold nanoparticles using leaf extract to inhibit lipopolysaccharide-induced inflammation through NF-κB and JAK/STAT pathways in RAW 264.7 macrophages. Int J Nanomedicine. 2019;14:2945–2959. doi:10.2147/IJN.S19978131114201
  • He W, Liu M, Li Y, et al. Flavonoids from Citrus aurantium ameliorate TNBS-induced ulcerative colitis through protecting colonic mucus layer integrity. Eur J Pharmacol. 2019;857:172456. doi:10.1016/j.ejphar.2019.17245631220438
  • Shen H, Xue J, Li T, et al. Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism. J Ethnopharmacol. 2018;216:47–56. doi:10.1016/j.jep.2018.01.02129366768
  • Watkins R, Wu L, Zhang C, Davis RM, Xu B. Natural product-based nanomedicine: recent advances and issues. Int J Nanomedicine. 2015;10:6055–6074. doi:10.2147/IJN.S9216226451111
  • Carter P, Narasimhan B, Wang Q. Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases. Int J Pharm. 2019;555:49–62. doi:10.1016/j.ijpharm.2018.11.03230448309
  • Poovaiah N, Davoudi Z, Peng H, et al. Treatment of neurodegenerative disorders through the blood–brain barrier using nanocarriers. Nanoscale. 2018;10:16962–16983. doi:10.1039/C8NR04073G30182106
  • Davoudi Z, Peroutka-Bigus N, Bellaire B, Wannemuehler M, Wang Q. Intestinal organoids containing PLGA nanoparticles for the treatment of inflammatory bowel diseases. J Biomed Mater Res A. 2017;106(4):876–886. doi:10.1002/jbm.a.3630529226615
  • Hajipour H, Hamishehkar H, Ahmad SNS, Barghi S, Maroufi NF, Taheri RA. Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers. Artif Cells Nanomed Biotechnol. 2018;46(sup1):283–292. doi:10.1080/21691401.2017.142349329310467
  • Zhang M, Xu C, Wang L, Merlin D. Oral delivery of nanoparticles loaded with ginger active compound, 6-shogaol, attenuates ulcerative colitis and promotes wound healing in a murine model of ulcerative colitis. J Crohns Colitis. 2018;12(2):217–229. doi:10.1093/ecco-jcc/jjx11528961808
  • Gao S, Tian B, Han J, et al. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. Int J Nanomedicine. 2019;14:6135–6150. doi:10.2147/IJN.S20529531447556
  • Du Q, Chen J, Yan G, et al. Comparison of different aliphatic acid grafted N-trimethyl chitosan surface-modified nanostructured lipid carriers for improved oral kaempferol delivery. Int J Pharm. 2019;568:118506. doi:10.1016/j.ijpharm.2019.11850631302169
  • Serafim TL, Oliveira PJ, Sardao VA, Perkins E, Parke D, Holy J. Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemother Pharmacol. 2008;61(6):1007–1018. doi:10.1007/s00280-007-0558-917661039
  • Yin J, Hou Y, Yin Y, Song X. Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect. Int J Nanomedicine. 2017;12:8671–8680. doi:10.2147/ijn.s14461529263662
  • Takashima T, Sakata Y, Iwakiri R, et al. Feeding with olive oil attenuates inflammation in dextran sulfate sodium-induced colitis in rat. J Nutr Biochem. 2014;25(2):186–192. doi:10.1016/j.jnutbio.2013.10.00524445043
  • Wullaert A, Bonnet MC, Pasparakis M. NF-κB in the regulation of epithelial homeostasis and inflammation. Cell Res. 2011;21(1):146–158. doi:10.1111/imr.1255021151201
  • Owczarek K, Koziołkiewicz M, Hrabec E, et al. Flavanols from Japanese quince (Chaenomeles japonica) fruit suppress expression of cyclooxygenase-2, metalloproteinase-9, and nuclear factor-kappaB in human colon cancer cells. Acta Biochim Pol. 2017;64(3):567–576. doi:10.18388/abp.2017_159928787469
  • Ain Q, Schmeer C, Penndorf D, et al. Cell cycle-dependent and -independent telomere shortening accompanies murine brain aging. Aging. 2018;10(11):3397–3420. doi:10.18632/aging.10165530472697
  • Xiang H, Lin L, Hu X, et al. AMPK activation attenuates inflammatory pain through inhibiting NF-κB activation and IL-1β expression. J Neuroinflammation. 2019;16:34. doi:10.1186/s12974-019-1411-x30755236